Date published: 2026-2-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

MPO Activators

Common MPO Activators include, but are not limited to Lipopolysaccharide, E. coli O55:B5 CAS 93572-42-0, PMA CAS 16561-29-8, GM-CSF CAS 83869-56-1, Forskolin CAS 66575-29-9 and Dexamethasone CAS 50-02-2.

Myeloperoxidase (MPO) is a lysosomal protein predominantly found in neutrophils, a type of white blood cell instrumental in the body's first line of defense against microbial invaders. MPO is a heme-containing enzyme, and its primary function lies in the catalysis of the conversion of hydrogen peroxide (H2O2) to hypochlorous acid (HOCl) in the presence of chloride ions. This reaction serves a dual purpose: while H2O2 can cause damage to host tissues, its conversion to HOCl generates a potent antimicrobial agent, essential for the neutrophil's bactericidal activity. Given this, MPO plays a pivotal role in the innate immune response, aiding in the rapid neutralization and clearance of pathogens from the body. The significance of MPO extends beyond its enzymatic function, as it also plays a role in modulating inflammatory responses and is involved in the formation of neutrophil extracellular traps, a mechanism by which neutrophils capture and neutralize microbes.

Activators of MPO are molecules or compounds that enhance the expression or enzymatic activity of MPO. These activators may function by upregulating the transcription or translation of the MPO gene, stabilizing the MPO protein structure, or increasing its catalytic efficiency. The presence of MPO activators can amplify the bactericidal capacity of neutrophils, optimizing the efficiency of the innate immune response. Exploring the domain of MPO activators offers a deep dive into the world of neutrophil biology and the intricate molecular mechanisms that underpin immune defense. As the complex dance of cellular immunology continues to be decoded, the role of MPO and its activators emerges as a key chapter, elucidating the molecular strategies that guard against microbial threats.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lipopolysaccharide, E. coli O55:B5

93572-42-0sc-221855
sc-221855A
sc-221855B
sc-221855C
10 mg
25 mg
100 mg
500 mg
$98.00
$171.00
$425.00
$1560.00
12
(2)

LPS stimulates neutrophils and can lead to the release of MPO. It binds to the TLR4 receptor, leading to the activation of NF-κB, which can induce MPO expression.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC), leading to the stimulation of neutrophils and the subsequent release of MPO.

GM-CSF

83869-56-1sc-280759
5 µg
$516.00
1
(0)

GM-CSF stimulates the differentiation of progenitor cells into granulocytes and monocytes, which can lead to increased MPO expression.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin increases intracellular cAMP levels, which can stimulate the release of MPO from neutrophils.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Dexamethasone has been shown to upregulate MPO mRNA levels in certain cell types, potentially leading to increased MPO protein expression.

1α,25-Dihydroxyvitamin D3

32222-06-3sc-202877B
sc-202877A
sc-202877C
sc-202877D
sc-202877
50 µg
1 mg
5 mg
10 mg
100 µg
$220.00
$645.00
$1000.00
$1500.00
$440.00
32
(2)

This active form of Vitamin D3 can stimulate the differentiation of myeloid cells, potentially leading to increased MPO expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

This compound can stimulate the differentiation of promyelocytic leukemia cells, potentially leading to increased MPO expression.

Dimethyl Sulfoxide (DMSO)

67-68-5sc-202581
sc-202581A
sc-202581B
100 ml
500 ml
4 L
$31.00
$117.00
$918.00
136
(6)

DMSO can induce differentiation in certain myeloid leukemia cell lines, which may lead to increased MPO expression.

1-β-D-Arabinofuranosylcytosine

147-94-4sc-201628
sc-201628A
sc-201628B
sc-201628C
sc-201628D
1 g
5 g
25 g
100 g
250 g
$150.00
$263.00
$518.00
$731.00
$1461.00
1
(1)

This agent has been shown to increase MPO expression in some settings, particularly in acute myeloid leukemia.

Hydrocortisone

50-23-7sc-300810
5 g
$102.00
6
(1)

Hydrocortisone can stimulate the differentiation of certain myeloid cells, potentially leading to increased MPO expression.